Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neurons

被引:32
作者
Dietrich, P
Rideout, HJ
Wang, QH
Stefanis, L
机构
[1] Columbia Univ, Dept Neurol, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
关键词
D O I
10.1016/S1044-7431(03)00201-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Proteasomal dysfunction may contribute to neurodegenerative diseases; however, its effects on primary neurons are largely unknown. We have previously reported that pharmacological proteasomal inhibition leads to apoptosis and cytoplasmic ubiquitinated inclusions in primary rat cortical neurons. In cell lines the transcription factor p53 is regulated by the proteasome and in some cases it mediates death following proteasomal inhibition. It is unclear, however, if this is the case in primary neurons. Here we show in proteasome inhibitor-treated cortical neurons an early increase of p53 levels, accompanied by nuclear translocation. At later time points p53 is found sequestered within ubiquitinated inclusions. Compared to controls, p53-deficient mouse neurons show delayed apoptosis, but increased numbers of inclusions, likely secondary to enhanced survival. We conclude that p53 plays a role in cortical neuron apoptosis induced by proteasomal inhibition and, despite the fact that it localizes to inclusions, it is not necessary for their formation. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:430 / 441
页数:12
相关论文
共 58 条
[1]   Protease inhibitor-induced apoptosis:: accumulation of wt p53, p21WAF1/CIP1 and induction of apoptosis are independent markers of proteasome inhibition [J].
An, WG ;
Hwang, SG ;
Trepel, JB ;
Blagosklonny, MV .
LEUKEMIA, 2000, 14 (07) :1276-1283
[2]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[3]  
Chen F, 2000, CELL GROWTH DIFFER, V11, P239
[4]   The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders [J].
Chung, KKK ;
Dawson, VL ;
Dawson, TM .
TRENDS IN NEUROSCIENCES, 2001, 24 (11) :S7-S14
[5]   ATTENUATION OF P53 EXPRESSION PROTECTS AGAINST FOCAL ISCHEMIC DAMAGE IN TRANSGENIC MICE [J].
CRUMRINE, RC ;
THOMAS, AL ;
MORGAN, PF .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (06) :887-891
[6]   Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73 [J].
Dietz, S ;
Rother, K ;
Bamberger, C ;
Schmale, H ;
Mössner, J ;
Engeland, K .
FEBS LETTERS, 2002, 525 (1-3) :93-99
[7]   p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism [J].
Duan, WZ ;
Zhu, XX ;
Ladenheim, B ;
Yu, QS ;
Guo, ZH ;
Oyler, J ;
Cutler, RG ;
Cadet, JL ;
Greig, NH ;
Mattson, MP .
ANNALS OF NEUROLOGY, 2002, 52 (05) :597-606
[8]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[9]  
FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V63, P1578
[10]   E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3 [J].
Giovanni, A ;
Keramaris, E ;
Morris, EJ ;
Hou, ST ;
O'Hare, M ;
Dyson, N ;
Robertson, GS ;
Slack, RS ;
Park, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :11553-11560